Patient and parent preferences for characteristics of prophylactic treatment in hemophilia

INTRODUCTION: New longer-acting factor products will potentially allow for less frequent infusion in prophylactic treatment of hemophilia. However, the role of administration frequency relative to other treatment attributes in determining preferences for prophylactic hemophilia treatment regimens is...

Descripción completa

Detalles Bibliográficos
Autores principales: Furlan, Roberto, Krishnan, Sangeeta, Vietri, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664548/
https://www.ncbi.nlm.nih.gov/pubmed/26648701
http://dx.doi.org/10.2147/PPA.S92520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664548/
https://www.ncbi.nlm.nih.gov/pubmed/26648701
http://dx.doi.org/10.2147/PPA.S92520

Ejemplares similares